SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-057126
Filing Date
2015-06-29
Accepted
2015-06-29 16:41:21
Documents
2
Period of Report
2015-06-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3872
2 EX-24 DOCUMENT attachment1.htm EX-24 4087
  Complete submission text file 0001209191-15-057126.txt   9448
Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Issuer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ACHILLION PHARMACEUTICALS 300 GEORGE STREET NEW HAVEN CT 06511
Business Address
Scheer David (Reporting) CIK: 0001378585 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34921 | Film No.: 15958791